title: Treatment with lenalidomide in myelodysplastic syndromes with deletion 5q: results from the Dutch named patient program.
authors.forename: Imane
authors.initials: I
authors.lastname: Abouyahya
authors.forename: Canan
authors.initials: C
authors.lastname: Alhan
authors.forename: Theresia M
authors.initials: TM
authors.lastname: Westers
authors.forename: Peter A
authors.initials: PA
authors.lastname: te Boekhorst
authors.forename: Mies C
authors.initials: MC
authors.lastname: Kappers-Klunne
authors.forename: Jules L
authors.initials: JL
authors.lastname: Coenen
authors.forename: Fenna H
authors.initials: FH
authors.lastname: Heyning
authors.forename: Gerwin A
authors.initials: GA
authors.lastname: Huls
authors.forename: Joost T
authors.initials: JT
authors.lastname: de Wolf
authors.forename: Alex L
authors.initials: AL
authors.lastname: Imholz
authors.forename: Harry R
authors.initials: HR
authors.lastname: Koene
authors.forename: Gerda
authors.initials: G
authors.lastname: Veth
authors.forename: Evert-Jan F M
authors.initials: EJ
authors.lastname: de Kruijf
authors.forename: Petra
authors.initials: P
authors.lastname: Muus
authors.forename: Erwin V
authors.initials: EV
authors.lastname: Planken
authors.forename: Christine M
authors.initials: CM
authors.lastname: Segeren
authors.forename: Wies L
authors.initials: WL
authors.lastname: Vasmel
authors.forename: Ankie M
authors.initials: AM
authors.lastname: van der Velden
authors.forename: Gerjo A
authors.initials: GA
authors.lastname: Velders
authors.forename: Jan
authors.initials: J
authors.lastname: Koedam
authors.forename: Gert J
authors.initials: GJ
authors.lastname: Ossenkoppele
authors.forename: Arjan A
authors.initials: AA
authors.lastname: van de Loosdrecht
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D006801:Humans; D000077269:Lenalidomide; D009190:Myelodysplastic Syndromes / Q000188:drug therapy* / Q000235:genetics* / Q000401:mortality; D009426:Netherlands; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D016896:Treatment Outcome; D044465:White People
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide